Dr Nick Adams n.adams5@rgu.ac.uk
Research Fellow B
A uniquely positive, self-described patient experience with the R-MAOI Moclobemide, prescribed for treatment-resistant-depression-anxiety.
Adams, Nicholas Norman
Authors
Abstract
Treatment-resistant clinical depression and linked-anxiety represents a serious debilitating illness. Individual presentation differs. Symptoms can be co-occurring depressive-state and high-anxiety [1], [2]. My own longitudinal experiences with depression-anxiety represent -at times- the above description. I also have a diagnosis of ADHD (diagnosed in childhood, re-diagnosed in adulthood). Over the last twenty-two-plus years, I was prescribed fifteen-plus antidepressant and associated medications, with little lasting positive effect from the SS/SNRIs, TCA and atypical medication families, with adjunctive medications/treatments also added. After a ten-year medication gap; relying on self-implemented coping routines and mechanisms, I felt in late-2022 that I was no longer able to manage recurrent, escalating depression-anxiety sufficiently without immediate pharmacological help. Moclobemide was suggested to me by a past psychiatrist over a decade ago (2012), however then another medication combination was trialled. I began Moclobemide in January 2023, prescribed from a different psychiatrist. This publication explores my experience with the unique positive effects of Moclobemide, drawing distinctions with other medications (and medication-classes) I have previously taken with little long-term positive effects.
Citation
ADAMS, N.N. 2024. A uniquely positive, self-described patient experience with the R-MAOI Moclobemide, prescribed for treatment-resistant-depression-anxiety. Psychiatry research [online], Articles in Press. Available from: https://doi.org/10.1016/j.psychres.2024.115924
| Journal Article Type | Letter |
|---|---|
| Acceptance Date | Apr 21, 2024 |
| Online Publication Date | Apr 25, 2024 |
| Deposit Date | Apr 25, 2024 |
| Publicly Available Date | Apr 26, 2025 |
| Journal | Psychiatry research |
| Print ISSN | 0165-1781 |
| Publisher | Elsevier |
| Peer Reviewed | Peer Reviewed |
| DOI | https://doi.org/10.1016/j.psychres.2024.115924 |
| Keywords | Mental health; Anxiety; Depression; Medication |
| Public URL | https://rgu-repository.worktribe.com/output/2308100 |
Files
This file is under embargo until Apr 26, 2025 due to copyright reasons.
Contact publications@rgu.ac.uk to request a copy for personal use.
You might also like
Lived experience of work and long COVID in healthcare staff.
(2023)
Journal Article
Towards resilience: examining complex and hybridised coping strategies used by NHS workers experiencing long COVID illness.
(2023)
Presentation / Conference
Understanding and supporting NHS employees with long COVID return to and remain in work: key barriers and facilitators.
(2023)
Presentation / Conference
Downloadable Citations
About OpenAIR@RGU
Administrator e-mail: publications@rgu.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search